Outcomes Among Mechanically Ventilated Patients With Severe Pneumonia and Acute Hypoxemic Respiratory Failure From SARS-CoV-2 and Other Etiologies

Abstract

ImportanceEarly observations suggested that COVID-19 pneumonia had a higher mortality rate than other causes of pneumonia.ObjectiveTo compare outcomes between mechanically ventilated patients with pneumonia due to COVID-19 (March 2020 to June 2021) and other etiologies (July 2016 to December 2019).Design, Setting, and ParticipantsThis retrospective cohort study was conducted at the Johns Hopkins Healthcare System among adult patients (aged ≥18 years) with pneumonia who required mechanical ventilation in the first 2 weeks of hospitalization. Clinical, laboratory, and mechanical ventilation data were extracted from admission to hospital discharge or death.ExposuresPneumonia due to COVID-19.Main Outcomes and MeasuresThe primary outcome was 90-day in-hospital mortality. Secondary outcomes were time to liberation from mechanical ventilation, hospital length of stay, static respiratory system compliance, and ventilatory ratio. Unadjusted and multivariable-adjusted logistic regression, proportional hazards regression, and doubly robust regression were used in propensity score–matched sets to compare clinical outcomes.ResultsOverall, 719 patients (mean [SD] age, 61.8 [15.3] years; 442 [61.5%] were male; 460 [64.0%] belonged to a minoritized racial group and 253 [35.2%] were White) with severe COVID-19 pneumonia and 1127 patients (mean [SD] age, 60.9 [15.8] years; 586 [52.0%] were male; 459 [40.7%] belonged to a minoritized racial group and 655 [58.1%] were White) with severe non–COVID-19 pneumonia. In unadjusted analyses, patients with COVID-19 pneumonia had higher 90-day mortality (odds ratio, 1.21, 95% CI 1.04-1.41), longer time on mechanical ventilation (subdistribution hazard ratio 0.72, 95% CI 0.63-0.81), and lower compliance (32.0 vs 28.4 mL/kg PBW/cm H2O; P < .001) when compared with those with non–COVID-19 pneumonia. In propensity score–matched analyses, patients with COVID-19 pneumonia were equally likely to die within 90 days as those with non–COVID-19 pneumonia (odds ratio, 1.04; 95% CI, 0.81 to 1.35; P = .85), had similar respiratory system compliance (mean difference, 1.82 mL/cm H2O; 95% CI, −1.53 to 5.17 mL/cm H2O; P = .28) and ventilatory ratio (mean difference, −0.05; 95% CI, −0.22 to 0.11; P = .52), but had lower rates of liberation from mechanical ventilation (subdistribution hazard ratio, 0.81; 95% CI, 0.65 to 1.00) when compared with those with non–COVID-19 pneumonia. Patients with COVID-19 pneumonia had somewhat lower rates of being discharged from the hospital alive at 90 days (subdistribution hazard ratio, 0.83; 95% CI, 0.68 to 1.01) than those with non–COVID-19 pneumonia; however, this was not statistically significant.Conclusions and RelevanceIn this study, mechanically ventilated patients with severe COVID-19 pneumonia had similar mortality rates as patients with other causes of severe pneumonia but longer times to liberation from mechanical ventilation. Mechanical ventilation use in COVID-19 pneumonia should follow the same evidence-based guidelines as for any pneumonia.

Impact of Sociodemographic and Hospital Factors on Inpatient Bilateral Reduction Mammaplasty: A National Inpatient Sample Analysis

“…A study of patients with sepsis and acute respiratory failure also found that Hispanic and Asian/Pacific Islander racial identification predicted shorter lengths of stay and attributed this potentially to preexisting differences in comorbidity severity or insurance payer status. 31 In our study, Hispanic patients were indeed an average of 1.1 points lower in comorbidity severity when compared with non-Hispanic patients, although this difference was not statistically significant. Such a relationship may explain the differences in trend directions found in length of stay between Black and Hispanic patients.…”

Machine Learning‐Led Optimization of Combination Therapy: Confronting the Public Health Threat of Extensively Drug Resistant Gram‐Negative Bacteria

“…3 The increased utilization of ventilators globally, especially in the context of extended usage related to severe severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2) infection, is likely only to exacerbate the problem of resistance among nosocomial gram-negatives moving forward. 4 Combination regimens are common among chemotherapy, in general, and occur more frequently when chemotherapy is being used to target resistant cell-types. In the case of combination antibiotic therapy, combination regimens are additionally complicated by critical illness, which can result in significant alterations to each drug's pharmacokinetics (PKs).…”

“…Furthermore, epidemiological studies have shown that mcr was likely present well before its 2016 report and consequently has spread much further than initially anticipated 3 . The increased utilization of ventilators globally, especially in the context of extended usage related to severe severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) infection, is likely only to exacerbate the problem of resistance among nosocomial gram‐negatives moving forward 4 …”